Cite
HARVARD Citation
Guo, X. et al. (n.d.). OP0244 Sustained Suppression of Rheumatoid Arthritis Disease Markers by Mavrilimumab but Not Golimumab in Anti-Tumor Necrosis Factor-Inadequate Responders: An Exploratory Analysis in The Phase IIB Earth Explorer 2 Clinical Trial. Annals of the rheumatic diseases. pp. 150-151. [Online].